(Q40796551)

English

Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

0 references

diffuse large B-cell lymphoma

1 reference

based on heuristic

inferred from title

Ganiraju Manyam

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111978%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Santiago Montes-Moreno

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111978%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Alexandar Tzankov

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111978%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111978%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Michael Boe Møller

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111978%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Miguel A. Piris

26

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111978%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111978%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111978%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Kristy L Richards

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111978%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Han van Krieken

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111978%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Zijun Y Xu-Monette

2

object named as

Zijun Y Xu-Monette

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111978%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

11

object named as

April Chiu

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111978%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

16

object named as

Eric D Hsi

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111978%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

William W L Choi

17

object named as

William W L Choi

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111978%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Maurilio Ponzoni

20

object named as

Maurilio Ponzoni

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111978%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Andrés J M Ferreri

21

object named as

Andrés J M Ferreri

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111978%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

29

object named as

Ken H Young

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111978%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

7

object named as

Carlo Visco

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111978%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

Ling Li

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111978%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Mark J Routbort

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111978%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Li Zhang

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111978%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Youli Zu

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111978%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Jooryung Huh

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111978%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Ben M Parsons

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111978%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Huilan Rao

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111978%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Jane N Winter

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111978%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Sa A Wang

27

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111978%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

L Jeffrey Medeiros

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111978%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Karen Dybkær

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111978%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

publication date

26 June 2015

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Modern Pathology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111978%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111978%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111978%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

1202-1213

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111978%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Multiple nuclear factors interact with the immunoglobulin enhancer sequences

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.76

21 January 2018

Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.76

21 January 2018

Genetic lesions in diffuse large B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.76

21 January 2018

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.76

21 January 2018

Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.76

21 January 2018

Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.76

21 January 2018

Constitutive BR3 receptor signaling in diffuse, large B-cell lymphomas stabilizes nuclear factor-κB–inducing kinase while activating both canonical and alternative nuclear factor-κB pathways

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.76

21 January 2018

EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.76

21 January 2018

Both FOXP1 and p65 expression are adverse risk factors in diffuse large B-cell lymphoma: a retrospective study in China.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.76

21 January 2018

Clinical significance of nuclear factor κB and chemokine receptor CXCR4 expression in patients with diffuse large B-cell lymphoma who received rituximab-based therapy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.76

21 January 2018

Prognostic impact of C-REL expression in diffuse large B-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.76

21 January 2018

Phenotype profiling of primary testicular diffuse large B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.76

21 January 2018

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Con

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.76

21 January 2018

MDM2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.76

21 January 2018

Clinical implications of phosphorylated STAT3 expression in De Novo diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.76

21 January 2018

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.76

21 January 2018

PQN and DQN: algorithms for expression microarrays.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.76

21 January 2018

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.76

21 January 2018

Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.76

21 January 2018

CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.76

21 January 2018

GCF2: expression and molecular analysis of repression.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.76

21 January 2018

Unique forms of human and mouse nuclear receptor corepressor SMRT

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.76

21 January 2018

FKHRL1-mediated expression of Noxa and Bim induces apoptosis via the mitochondria in neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.76

21 January 2018

Targeting dual-specificity phosphatases: manipulating MAP kinase signalling and immune responses.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.76

21 January 2018

Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at 21q11-21 in human lung cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.76

21 January 2018

The retinoblastoma protein-associated transcription repressor RBaK interacts with the androgen receptor and enhances its transcriptional activity.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.76

21 January 2018

HBP2: a new mammalian protein that complements the fission yeast MBF transcription complex

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.76

21 January 2018

TRAF1 is involved in the classical NF-kappaB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.76

21 January 2018

CD30 activates both the canonical and alternative NF-kappaB pathways in anaplastic large cell lymphoma cells

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.76

21 January 2018

Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.76

21 January 2018

BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.76

21 January 2018

RelB inhibits cell proliferation and tumor growth through p53 transcriptional activation.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.76

21 January 2018

Regulation of p53 tumour suppressor target gene expression by the p52 NF-kappaB subunit

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.76

21 January 2018

p53 represses cyclin D1 transcription through down regulation of Bcl-3 and inducing increased association of the p52 NF-kappaB subunit with histone deacetylase 1.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.76

21 January 2018

Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.76

21 January 2018

Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.76

21 January 2018

NFκB expression is a feature of both activated B-cell-like and germinal center B-cell-like subtypes of diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.76

21 January 2018

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/26111978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of the NF-kappaB signalling pathway in diffuse large B-cell lymphoma: clinical implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/26111978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The biological and clinical impact of inhibition of NF-κB-initiated apoptosis in diffuse large B cell lymphoma (DLBCL)

1 reference

https://pubmed.ncbi.nlm.nih.gov/26111978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization

1 reference

https://pubmed.ncbi.nlm.nih.gov/26111978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/MODPATHOL.2015.76

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111978%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26111978%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40796551&oldid=2261980674"